» Articles » PMID: 32810306

Removal of Dental Amalgam Restorations in Patients with Health Complaints Attributed to Amalgam: A Prospective Cohort Study

Overview
Journal J Oral Rehabil
Specialty Dentistry
Date 2020 Aug 19
PMID 32810306
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The Norwegian Ministry of Health and Care Services initiated a project including experimental treatment for patients with health complaints attributed to amalgam restorations.

Objective: The aim was to evaluate changes of general health complaints in patients who participated in the project and had all amalgam restorations removed.

Methods: The project was designed as a prospective cohort study and organised by the Dental Biomaterials Adverse Reaction Unit in Bergen, Norway. The dental treatment was provided by the patient's local dentist. The main target group consisted of patients with medically unexplained physical symptoms, attributed to dental amalgam restorations (Amalgam cohort). The primary comparison group consisted of patients with medically unexplained physical symptoms without attribution to dental amalgam restorations (MUPS cohort). Primary outcome was self-reported general health complaints (GHC index) at follow-up 12-months after completed amalgam removal.

Results: In the Amalgam cohort, a significant reduction of GHC index from 43.3 (SD 17.8) at baseline to 30.5 (SD 14.4) at follow-up (mean reduction 12.8, SD 15.9; n = 32; P < .001) was observed. The change scores for GHC index indicated that the reduction of complaints was significantly higher (P = .004) in the Amalgam cohort compared with the MUPS cohort (mean reduction 1.2, SD 12.3, n = 28). After adjustment for age, gender, education and baseline GHC index, the mean adjusted difference was -8.0 (95% confidence interval from -15.4 to -0.5; P = .036).

Conclusion: In a group of patients with medically unexplained physical symptoms, which they attributed to dental amalgam restorations, removal of amalgam restorations was followed by a significant reduction of health complaints.

Citing Articles

Evaluating the accuracy of Chat Generative Pre-trained Transformer version 4 (ChatGPT-4) responses to United States Food and Drug Administration (FDA) frequently asked questions about dental amalgam.

Buldur M, Sezer B BMC Oral Health. 2024; 24(1):605.

PMID: 38789962 PMC: 11127407. DOI: 10.1186/s12903-024-04358-8.


Health complaints before and at one and five years after removal of dental amalgam restorations - data from a prospective cohort study in Norway.

Sinha N, Hamre H, Musial F, L Werner E, Bjorkman L Acta Odontol Scand. 2024; 83:219-229.

PMID: 38699922 PMC: 11302653. DOI: 10.2340/aos.v83.40260.


Is amalgam removal in patients with medically unexplained physical symptoms cost-effective? A prospective cohort and decision modelling study in Norway.

Lamu A, Bjorkman L, Hamre H, Alraek T, Musial F, Robberstad B PLoS One. 2022; 17(4):e0267236.

PMID: 35486640 PMC: 9053791. DOI: 10.1371/journal.pone.0267236.


Validity and responsiveness of EQ-5D-5L and SF-6D in patients with health complaints attributed to their amalgam fillings: a prospective cohort study of patients undergoing amalgam removal.

Lamu A, Bjorkman L, Hamre H, Alraek T, Musial F, Robberstad B Health Qual Life Outcomes. 2021; 19(1):125.

PMID: 33865400 PMC: 8052827. DOI: 10.1186/s12955-021-01762-4.